Text Size

Long-Term Safety and Effectiveness of Diquafosol for the Treatment of Dry Eye in a Real-World Setting: A Prospective Observational Study

Ohashi Y., Munesue M., Shimazaki J., Takamura E., Yokoi N., Watanabe H., Nomura A., Shimada F.


  • 2020
  • Advances in Therapy
View publication
  • Therapeutic Area

    Front of the eye (FOTE)

  • Categories

    Clinical development

  • Affiliations

    Ehime University, Dogo-Himata, Matsuyama, Ehime, Japan; Santen Pharmaceutical Co., Ltd, Ofukacho, Kita-ku, Osaka, Japan; Tokyo Dental College Ichikawa General Hospital, Ichikawa, Chiba, Japan; School of Medicine, Tokyo Women’s Medical University, Kawada-cho, Shinjuku-ku, Tokyo, Japan; Kyoto Prefectural University of Medicine, Kajii-cho, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto, Japan; Kansai Rosai Hospital, Inabaso, Amagasaki, Hyogo, Japan

Related Publications

Burden of Vernal Keratoconjunctivitis in the United States: A Retrospective Claims Database Analysis

Koo E.B.; Yu T.M.; Layton A.J.; Babineaux S.; Fung S.


Review of clinical outcomes of a cationic emulsion tear substitute in patients with dry eye disease

Labetoulle M, Garhöfer G, Ismail D, Garrigue JS, Amrane M, Guillon M, Aragona P, Baudouin C.


Epinastine Cream: A Novel Once-Daily Therapeutic Agent for Allergic Conjunctivitis

Ogura N., Fujisawa K., Kato M.


Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022